5-(4-cyclopropyl-6-methoxyindazol-1-yl)-1-oxo-1,2-thiazol-3-one;5-[5-[6-(3,3-difluoropyrrolidin-1-yl)-3-pyridinyl]indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4,6-dimethyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;7-[1-(1,3-dioxo-1,2-thiazol-5-yl)indazol-5-yl]-4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazine-6-carbonitrile;5-[6-methoxy-4-(2-pyrrolidin-1-yl-4-pyridinyl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;tetracosa-2,4,6,8,10,12,14,16,18,20,22-undecayne
C115H84F2N24O14S5 — CID 157440456
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(4-cyclopropyl-6-methoxyindazol-1-yl)-1-oxo-1,2-thiazol-3-one;5-[5-[6-(3,3-difluoropyrrolidin-1-yl)-3-pyridinyl]indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4,6-dimethyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;7-[1-(1,3-dioxo-1,2-thiazol-5-yl)indazol-5-yl]-4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazine-6-carbonitrile;5-[6-methoxy-4-(2-pyrrolidin-1-yl-4-pyridinyl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;tetracosa-2,4,6,8,10,12,14,16,18,20,22-undecayne
5-(4-cyclopropyl-6-methoxyindazol-1-yl)-1-oxo-1,2-thiazol-3-one;5-[5-[6-(3,3-difluoropyrrolidin-1-yl)-3-pyridinyl]indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4,6-dimethyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;7-[1-(1,3-dioxo-1,2-thiazol-5-yl)indazol-5-yl]-4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazine-6-carbonitrile;5-[6-methoxy-4-(2-pyrrolidin-1-yl-4-pyridinyl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;tetracosa-2,4,6,8,10,12,14,16,18,20,22-undecayne (PubChem CID 157440456) has the molecular formula C115H84F2N24O14S5 and a molecular weight of 2224.42 g/mol. Its IUPAC name is 5-(4-cyclopropyl-6-methoxyindazol-1-yl)-1-oxo-1,2-thiazol-3-one;5-[5-[6-(3,3-difluoropyrrolidin-1-yl)-3-pyridinyl]indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4,6-dimethyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;7-[1-(1,3-dioxo-1,2-thiazol-5-yl)indazol-5-yl]-4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazine-6-carbonitrile;5-[6-methoxy-4-(2-pyrrolidin-1-yl-4-pyridinyl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;tetracosa-2,4,6,8,10,12,14,16,18,20,22-undecayne.
Molecular Properties
| Compound Name | 5-(4-cyclopropyl-6-methoxyindazol-1-yl)-1-oxo-1,2-thiazol-3-one;5-[5-[6-(3,3-difluoropyrrolidin-1-yl)-3-pyridinyl]indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4,6-dimethyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;7-[1-(1,3-dioxo-1,2-thiazol-5-yl)indazol-5-yl]-4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazine-6-carbonitrile;5-[6-methoxy-4-(2-pyrrolidin-1-yl-4-pyridinyl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;tetracosa-2,4,6,8,10,12,14,16,18,20,22-undecayne |
|---|---|
| PubChem CID | 157440456 |
| Molecular Formula | C115H84F2N24O14S5 |
| Molecular Weight | 2224.42 g/mol |
| Exact Mass | 2222.52 |
| IUPAC Name | 5-(4-cyclopropyl-6-methoxyindazol-1-yl)-1-oxo-1,2-thiazol-3-one;5-[5-[6-(3,3-difluoropyrrolidin-1-yl)-3-pyridinyl]indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4,6-dimethyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;7-[1-(1,3-dioxo-1,2-thiazol-5-yl)indazol-5-yl]-4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazine-6-carbonitrile;5-[6-methoxy-4-(2-pyrrolidin-1-yl-4-pyridinyl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;tetracosa-2,4,6,8,10,12,14,16,18,20,22-undecayne |
| SMILES | CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CN1CCOc2cc(-c3ccc4c(cnn4C4=CC(=O)NS4=O)c3)c(C#N)nc21.COc1cc(-c2ccnc(N3CCCC3)c2)c2cnn(C3=CC(=O)NS3=O)c2c1.COc1cc(C2CC2)c2cnn(C3=CC(=O)NS3=O)c2c1.Cc1nc2c(cc1-c1ccc3c(cnn3C3=CC(=O)NS3=O)c1)OCCN2C.O=C1C=C(n2ncc3cc(-c4ccc(N5CCC(F)(F)C5)nc4)ccc32)S(=O)N1 |
| InChI | InChI=1S/C24H6.C20H19N5O3S.C19H15F2N5O2S.C19H14N6O3S.C19H17N5O3S.C14H13N3O3S/c1-3-5-7-9-11-13-15-17-19-21-23-24-22-20-18-16-14-12-10-8-6-4-2;1-28-14-9-15(13-4-5-21-18(8-13)24-6-2-3-7-24)16-12-22-25(17(16)10-14)20-11-19(26)23-29(20)27;20-19(21)5-6-25(11-19)16-4-2-13(9-22-16)12-1-3-15-14(7-12)10-23-26(15)18-8-17(27)24-29(18)28;1-24-4-5-28-16-7-13(14(9-20)22-19(16)24)11-2-3-15-12(6-11)10-21-25(15)18-8-17(26)23-29(18)27;1-11-14(8-16-19(21-11)23(2)5-6-27-16)12-3-4-15-13(7-12)10-20-24(15)18-9-17(25)22-28(18)26;1-20-9-4-10(8-2-3-8)11-7-15-17(12(11)5-9)14-6-13(18)16-21(14)19/h1-2H3;4-5,8-12H,2-3,6-7H2,1H3,(H,23,26);1-4,7-10H,5-6,11H2,(H,24,27);2-3,6-8,10H,4-5H2,1H3,(H,23,26);3-4,7-10H,5-6H2,1-2H3,(H,22,25);4-8H,2-3H2,1H3,(H,16,18) |
| InChIKey | BRPPFGFCEKHUGN-UHFFFAOYSA-N |
| XLogP | 10.63 |
| TPSA | 445.18 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 160 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2224.42 |
| LogP ≤ 5 | 10.63 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 33 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157440456 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.